What is Advanced Analytical Laboratory?
Advanced Analytical Laboratory (AATL) specializes in comprehensive raw material testing for the qualification of Active Pharmaceutical Ingredients (API) and Excipients. The company offers critical Residual Solvent Testing, adhering to current USP standards and client-specific validated methods for both raw material and finished product release. AATL's extensive laboratory instrumentation includes advanced systems such as HPLC and GC for potency assays and impurity analysis, FTIR and UV-VIS spectrophotometers for identification, and specialized equipment for dissolution, refractive index, total organic carbon, conductivity, pH, melting point, specific rotation, viscosity, and Karl Fischer titrations. This robust analytical capability positions AATL as a key partner for pharmaceutical manufacturers requiring stringent quality control and regulatory compliance.
How much funding has Advanced Analytical Laboratory raised?
Advanced Analytical Laboratory has raised a total of $323K across 2 funding rounds:
Debt
$150K
Debt
$173K
Debt (2020): $150K with participation from PPP
Debt (2021): $173K led by PPP
Key Investors in Advanced Analytical Laboratory
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Advanced Analytical Laboratory?
With a substantial funding history and a recent major strategic investment, Advanced Analytical Laboratory is poised for significant growth. The company's focus on essential pharmaceutical quality control services suggests potential expansion into new therapeutic areas, increased capacity to meet growing industry demand, or further technological advancements in its analytical offerings. This capital infusion will likely fuel strategic initiatives aimed at solidifying its market leadership and enhancing its service portfolio, ensuring continued compliance with evolving regulatory landscapes and client needs.
See full Advanced Analytical Laboratory company page
